SCHEMBL3510122

SCHEMBL3510122

CCP(=O)(O)Cc1cccc(Br)n1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PGK1 P00558 1/20 0.50
PGK2 P07205 1/20 0.50
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
MBOAT4 Q96T53 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35
GRM5 P41594 1/20 0.34
FAAH O00519 1/20 0.34
PARP1 P09874 1/20 0.33
ACKR3 P25106 1/20 0.33
KDM1A O60341 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
HTR7 P34969 2/20 0.31
HTR1A P08908 1/20 0.31
DRD2 P14416 1/20 0.31
HTR2A P28223 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3674807 0.83 PGK1 (0.53) PGK1PGK2ALDH1A1HPGDMBOAT4
SCHEMBL4542167 0.82 PGK1 (0.74) PGK1PGK2ALDH1A1HPGDFAAH
SCHEMBL30669248 0.75 PGK1 (0.41) PGK1PGK2HPGDMBOAT4CHRNB2
SCHEMBL13640312 0.75 PGK1 (0.41) PGK1PGK2HPGDMBOAT4CHRNB2
SCHEMBL26972709 0.74 PGK1 (0.40) PGK1PGK2HPGDMBOAT4CHRNB2
SCHEMBL3510117 0.73 PGK1 (0.42) PGK1PGK2ALDH1A1HPGDMBOAT4
SCHEMBL906702 0.72
Naphthalene SCHEMBL31315623 0.69 CETP (0.41) ALDH1A1
SCHEMBL2485221 0.69 KCNH2 (0.50) ALDH1A1HPGDMBOAT4PARP1KDM1A
SCHEMBL6564804 0.68 NPSR1 (0.43) PGK1PGK2ALDH1A1HPGDMBOAT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367706-B2 Inhibitors of janus kinases MERCK SHARP & DOHME CORP. (US) 2013-02-05 US disclosed
US-20100256097-A1 INHIBITORS OF JANUS KINASES MERCK SHARP & DOHME LLC 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256097-A1 INHIBITORS OF JANUS KINASES JAK2, JAK3, JAK1 PGK1 232/4885PGK2 227/4885ALDH1A1 3244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.